Conference highlights Japanese vaccine therapy for cancers

Wednesday, Apr 03, 2019 09:00

Dr Kenichiro Hasumi discusses the Human Initiated Therapeutic Vaccine Therapy, a technique he pioneered to treat cancers, with Vietnamese doctors at a conference titled Vaccine Hasumi- immunotherapy for Cancers at the Gia An 115 Hospital in HCM City. — Photo courtesy of the Gia An 115 Hospital

Cancer treatment has seen great progress with advanced technologies being adopted around the world in recent years.

In immunotherapy too, many kinds of medicines have been developed. CAR-T immunotherapy has much attention from the scientific community.

Human Initiated Therapeutic Vaccine (HITV) Therapy is a technique developed in Japan through ICVS Tokyo Clinic’s unique protocol.

It utilizes dendritic cells and activated memory T-cells collected and induced from a patient’s blood, Japan’s Dr Kenichiro Hasumi who has done research into cancer vaccines, said.

His research for more than 40 years has been focusing on immunotherapy for cancer.

In 14 years since HITV was introduced, the rate of cancer remission has reached 70 per cent.

Since 2008 more than 1,200 cancer patients have been treated, resulting in a reduction in the rate of recurrence of cancer cells.

By utilising tomotherapy that is capable of delivering Intensity-Modulated Radiation Therapy, HITV can destroy tumours in an efficient manner and have a less harmful impact on normal, healthy cells.

It is capable of treating multiple lesions. In most cases when patients are diagnosed with a relapse of advanced cancer with multiple metastasis, a hope for cure is abandoned, but this can be performed even on patients with advanced-stage cancer.

It can treat all cancer types with only one exception-blood cancer. It is capable of retreating relapsing cancer that reappears in the same or different sites in the body.

The information about the therapy was presented at a conference titled Vaccine Hasumi- immunotherapy for Cancers at the Gia An 115 Hospital in HCM City’s Binh Tan District.

The conference attracted experts and doctors from major hospitals in the city.

In Viet Nam, cancers are an increasing burden with nearly 165,000 cases found last year. Of them, nearly 70 per cent died, according to a report by K (Cancer) Hospital.

Gia An 115 Hospital is the second medical facility to come up at the Hoa Lam Shangri-La Hi-Tech Healthcare Park in Binh Tan District. It is licensed as a general hospital, with specialty departments such as cardiology, neurology-stroke, endocrinology, orthopedics, and physiotherapy-rehabilitation.

It has 367 beds and 60 rooms for examination. With Hoa Lam Corporation and People’s Hospital 115 jointly owning it, it is the first hospital run under the public-private partnership (PPP) model in the country.

It helps address the overcrowding at city-level public hospitals. The PPP model also contributes to improving the quality of healthcare especially in the west of the city.

Built at a cost of VND1.5 trillion, it is well equipped for professional treatment. It also has expert personnel, many of whom trained abroad.

Experts from People’s Hospital 115 also treat patients here.


Comments (0)